Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sentinel Lymph Node Sampling Versus Systematic Pelvic Lymphadenectomy on the Prognosis for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus Before Surgery: a Non-inferiority Randomized Controlled Trial

NCT04276532 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.

NCT NCT04276532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sentinel Lymph Node Sampling Versus Systematic Pelvic Lymphadenectomy on the Prognosis for Patients With Middle-high Risk Endometrial Cancer Confined to the Uterus Before Surgery: a Non-inferiority Randomized Controlled Trial
Lead sponsor
Xiaojun Chen
Phase
Not applicable
Overall status
Active, not recruiting
Start date
February 13, 2020
Completion date
February 12, 2030
Enrollment
780 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

middle-high risk endometrial cancer, prognosis, sentinel lymph node sampling